Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers.
暂无分享,去创建一个
D. Clayton | A. Bird | A. Moore | T. Sepp | J. Yates | J. Khan | H. Shahid | Anthony T Moore | Alan C Bird | David G Clayton | D. Thurlby | John R W Yates | Humma Shahid | Tiina Sepp | Jane C Khan | Deborah A Thurlby | A. Moore
[1] G. Hageman,et al. Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.
[2] B S Hawkins,et al. Epidemiology of age-related macular degeneration. , 1999, Molecular vision.
[3] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[4] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[5] Association Between C-Reactive Protein and Age-Related Macular Degeneration , 2004 .
[6] Jurg Ott,et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.
[7] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] B. Ghebrehiwet,et al. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. , 1985, The Journal of clinical investigation.
[9] L. Almasy,et al. Genetic and environmental factors influencing the human factor H plasma levels , 2004, Immunogenetics.
[10] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[11] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] N. Day,et al. Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. , 2003, Atherosclerosis.
[13] J. Twisk,et al. Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. , 2001, Addiction.
[14] G. Deschênes,et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.
[15] S. Rodríguez de Córdoba,et al. The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.
[16] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[17] A. Moore,et al. Genetic susceptibility to age related macular degeneration , 2000, Journal of medical genetics.